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Genes Associated With the Long QT Syndrome
Clinical Relevance
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Objectives The aim of this study was to investigate, in a set of 93 mutation-negative long QT syndrome (LQTS) probands,
the frequency of copy number variants (CNVs) in LQTS genes.
Background LQTS is an inherited cardiac arrhythmia characterized by a prolonged heart rate–corrected QT (QTc) interval as-
sociated with sudden cardiac death. Recent studies suggested the involvement of duplications or deletions in
the occurrence of LQTS. However, their frequency remains unknown in LQTS patients.
Methods Point mutations in KCNQ1, KCNH2, and SCN5A genes were excluded by denaturing high-performance liquid
chromatography or direct sequencing. We applied Multiplex Ligation-dependent Probe Amplification (MLPA) to
detect CNVs in exons of these 3 genes. Abnormal exon copy numbers were confirmed by quantitative multiplex
PCR of short fluorescent fragment (QMPSF). Array-based comparative genomic hybridization (array CGH) analysis
was performed using Agilent Human Genome 244K Microarrays to further map the genomic rearrangements.
Results We identified 3 different deletions in 3 unrelated families: 1 in KCNQ1 and 2 involving KCNH2. We showed in
the largest family that the deletion involving KCNH2 is fully penetrant and segregates with the long QT pheno-
type in 7 affected members.
Conclusions Our study demonstrates that CNVs in KCNQ1 and KCNH2 explain around 3% of LQTS in patients with no point
mutation in these genes. This percentage is likely higher than the frequency of point mutations in ANKB, KCNE1,
KCNE2, KCNJ2, CACNA1C, CAV3, SCN4B, AKAP9, and SNTA1 together. Thus, we propose that CNV screening in
KCNQ1 and KCNH2 may be performed routinely in LQTS patients. (J Am Coll Cardiol 2011;57:40–7) © 2011
by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.08.621s
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eong QT syndrome (LQTS) is an inherited cardiac ar-
hythmia characterized by a prolonged heart rate–corrected
T (QTc) interval, which is associated with syncope and
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ccepted August 10, 2010.udden death caused by torsades de pointes or polymorphic
entricular tachycardia. LQTS can be an autosomal reces-
ive disorder (1), but the most common form is an autoso-
al dominant disorder called Romano-Ward syndrome
See page 48
2,3). LQTS affects between 1 in 5,000 and 1 in 2,000
ndividuals (4,5). Molecular diagnosis is an important tool
o guide diagnosis, treatment, and prevention strategies in
QTS patients. To date, more than 600 mutations (6) have
een identified among 12 different genes: 5 genes encoding
on channel alpha subunits (KCNQ1 [7], KCNH2 [8],
CN5A [9], KCNJ2 [10], and CACNA1C [11]) and 7 genes
ncoding ion channel regulatory proteins (ANKB [12],
CNE1 [13], KCNE2 [14], CAV3 [15], SCN4B [16],
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is can resolve up to 70% of cases. More than 90% of those
ases are due to mutations in KCNQ1, KCNH2, and SCN5A,
orresponding to LQT1, LQT2, and LQT3, respectively
19,20). The lack of mutation detection in the remaining cases
as been attributed to phenotyping errors, incomplete sensi-
ivity of screening methods (denaturing high-performance
iquid chromatography [dHPLC]) and direct sequencing),
utations in noncoding regions, or mutations in as of yet
nknown genes.
Another source of negative molecular screening could be
he presence of copy number variants (CNVs) affecting the
ajor genes for LQTS, that would not be detectable using
apillary sequencing. Interestingly, Bisgaard et al. (21)
escribed in 2006 a large deletion (217 genes) including
CNH2 in a patient with mental retardation and a LQTS.
n addition, Koopmann et al. (22) detected a 3.7-kb
ntragenic KCNH2 duplication in a Dutch family affected by
QTS. More recently, Eddy et al. (23) identified 2 dele-
ions—1 in KCNQ1, a second in KCNH2—and a duplica-
ion in KCNH2 in LQTS patients. These different studies
uggest that gene duplications or deletions can explain
QTS. However, the precise frequency of CNVs involving
he main LQTS genes in patients with LQTS remains
nknown. In this study, we investigated the involvement of
are deletions and duplications affecting KCNH2 and
CNQ1 in 93 probands with LQTS and in particular in 1
arge family for which no putatively causative point muta-
ions had been identified previously.
ethods
QTS patients. This study was in agreement with the
ocal guidelines for genetic research and has been approved
y the local ethical committee. Two experts for rare arrhyth-
ic diseases at the University Hospital of Nantes defined
he LQTS phenotype by independent electrocardiogram
ECG) readings. Diagnosis of LQT syndrome was based on
he QTc duration, the morphology of the T-wave, and the
atient’s clinical and family history. The Schwartz score has
lso been calculated for the 93 patients, and all of them have
Schwartz score of 3 or greater. QTc duration was
alculated according to Bazett’s formula. A prolongation of
he QTc duration was defined as 440 ms for men
borderline between 430 and 439 ms) and as 460 ms for
omen (borderline between 450 and 459 ms) (24). Each
atient underwent full medical examination to rule out
yndromic forms of QT prolongation. Blood samples were
ollected after written informed consent. Mutations in
oding regions and exon–intron boundaries for the 3 main
QTS-causing genes—KCNQ1, KCNH2, and SCN5A—
ere excluded by dHPLC or direct sequencing.
LPA, QMPSF, and qPCR analyses. Multiplex Ligation-
ependent Probe Amplification (MLPA) was performed
sing the SALSA P114 MLPA kit (MRC-Holland,
msterdam, the Netherlands) and according to the SRC-Holland protocol (25). The
ALSA P114 MLPA kit contains
0 probes interrogating the
CNQ1 gene, 9 for the KCNH2
ene, and 3 for the SCN5A gene.
bnormal profiles in MLPA anal-
sis were completed with a locus-
pecific Quantitative Multiplex
CR of Short Fluorescent Frag-
ent (QMPSF) (26) ( see the
upplemental Online Methods).
ligonucleotide complementary
equences to exons 5 and 15 of
CNH2 or exon 7, intron 7-8, and
xon 8 of KCNQ1 were coampli-
ed by PCR with an additional
ragment, corresponding to exon
4 of MLH1, a gene located on
hromosome 11 used as a control.
he QMPSF conditions and
rimer sequences are available
pon request. Quantitative PCR
qPCR) experiments were per-
ormed using the LightCycler
80 (Roche Molecular Systems, Mannheim, Germany) to
alidate genes with variable copy number. PCR reactions
ere prepared using the Power SYBR-Green PCR reagent
it (Applied Biosystems, Foster City, California) according
o the manufacturer’s protocol.
rray comparative genomic hybridization. Array com-
arative genomic hybridization (CGH) analysis was per-
ormed using the Agilent Human Genome Microarray Kit
44A (Agilent Technologies, Santa Clara, California). La-
eling, hybridization, washes, and data analysis were per-
ormed according to the protocol provided by Agilent
Protocol version 4.0, June 2006). Graphical overviews were
btained using the CGH Analytics software (version 3.4,
gilent Technologies). DNA sequence information refers
o the public UCSC Genome Browser database (Human
enome Browser, March 2006 Assembly).
inkage analysis. Two-point linkage analysis was performed
ith easy LINKAGE Plus software (version 5.02), by using an
utosomal-dominant model of inheritance with complete pen-
trance and a disease allele frequency of 0.001 (T. Lindner,
niversity of Würzburg, Würzburg, Germany).
esults
inety-three patients with LQTS were included in this
tudy. No potentially causative point mutations in the
CNQ1, KCNH2, and SCN5A genes were identified by
HPLC or direct sequencing in any of these individuals.
he patients (63% women) showed an average QTc dura-
ion of 556  60 ms and an average age at diagnosis of 35
22 years. Among the 93 patients, 33 (36%) have a
Abbreviations
and Acronyms
CGH  comparative
genomic hybridization
CNV  copy number variant
dHPLC  denaturing high-
performance liquid
chromatography
ECG  electrocardiogram/
eclectrocardiographic
ICD  implantable
cardioverter-defibrillator
LOD  logarithm of the
odds
LQTS  long QT syndrome
MLPA  Multiplex Ligation-
dependent Probe
Amplification
QMPSF  quantitative
multiplex PCR of short
fluorescent fragment
QTc  heart
rate–corrected QT intervalchwartz score of 3 and 60 (64%) show a Schwartz score
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Copy Number Variation in LQTS Genes December 28, 2010/January 4, 2011:40–7f 4 or greater. Twenty-three patients (25%) had been
esuscitated from sudden cardiac death, 58 (62%) had
resented with a syncope, 30 (32%) with an arrhythmia
vent, and 15 (16%) had been implanted with an im-
lantable cardioverter-defibrillator (ICD). The T-wave
atterns for all patients were classified into 5 categories:
ormal T-wave morphology (n  3, 3%), LQT1 (n  11,
2%), LQT2 (n  47, 51%), LQT3 (n  13, 14%), and
onspecific (n  19, 20%).
We screened for CNV involving the KCNQ1, KCNH2,
nd SCN5A genes in these 93 patients, by MLPA. We
dentified 1 heterozygote deletion in KCNQ1 and 2 hetero-
ygote deletions involving KCNH2 in 3 unrelated patients.
o CNVs were detected in SCN5A. Familial investigations
ere carried out for those 3 cases.
amily 1. Patient III:4 was diagnosed for LQTS after the
Figure 1 Family 1: Clinical Findings
(A) The disease phenotype is transmitted as an autosomal-dominant trait. Open s
undetermined members; and question marks, unknown phenotypes. Circles indica
marked with / for heterozygous mutation and / for wild type. Heart rate-co
Proband’s electrocardiogram (ECG) of arrhythmias is presented. (B) ECGs are presccurrence of several episodes of torsades de pointes and 1entricular fibrillation successfully resuscitated at age 23 years.
er ECG showed a prolonged QT interval (QTc  554 ms)
nd a bifid T-wave strongly suggestive of LQT2 syndrome
Fig. 1). Because of the aborted cardiac arrest, she was
mplanted with an ICD. Her clinical examination found no
ther abnormalities. Familial recruitment led to the identifica-
ion of 16 relatives through 3 generations (Fig. 1A). In
ddition to patient III:4, 6 family members had ECG abnor-
alities strongly suggestive of LQTS (Fig. 1B): patient I:2
QTc  465 ms), patient II:1 (QTc  590 ms), patient II:7
QTc 615 ms), patient III:1 (QTc 670 ms), patient III:5
QTc 518 ms), and patient III:6 (QTc 610 ms). Each of
hese relatives was asymptomatic. ECGs performed in the
ther family members were normal (data not shown).
Using MLPA and QMPSF, a heterozygote genomic
eletion was identified in patient III:4 involving exons 4 to
s depict unaffected members; solid symbols, long QT phenotypes; gray symbols,
ales; and squares, males. The proband is indicated by an arrow. Genotypes are
QT interval (QTc) values (Bazett formula) are indicated below each individual.
for affected members. ICD  implantable cardioverter-defibrillator.ymbol
te fem
rrected
ented4 of KCNH2 (Fig. 2A).
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December 28, 2010/January 4, 2011:40–7 Copy Number Variation in LQTS GenesQMPSF was performed using 2 probes: the first in exon
confirmed the deletion, and the second in exon 15
emonstrated that the 3= coding region of KCNH2 was also
eleted (data not shown).
High-resolution array CGH analysis refined the size of the
enomic rearrangement: the deletion, delimited by probes
_16_P18164054 (intron 3-4, centromeric breakpoint) to
_16_P01835269 (telomeric breakpoint), is 650 kb in length.
ineteen other genes are included in this rearrangement
including ABP1) (Fig. 3A), which maps to band 7q36.1.
Interestingly, Redon et al. (27) identified a CNV in ABP1
ownstream of the KCNH2 gene in individual NA12762
chr7: 149, 976, 469–150, 101, 345) from the HapMap
ollection. We checked whether KCNH2 is encompassed by
his CNV, using QMPSF on KCNH2 exons 5 and 15 and
BP1 exon 2. We found that the deletion identified by
edon et al. is limited to ABP1 and does not affect KCNH2
data not shown).
The KCNH2 CNV was present in the 6 other affected
amily members (I:2, II:1, II:7, III:1, III:5, and III:6) but
Figure 2 Detection of CNVs Involving the KCNH2 and KCNQ1 G
Each profile corresponds to relative peak ratios for control probes, KCNH2, KCNQ1
4 to 14 are deleted in Family 1; (B) KCNH2/exons 1 to 14 are deleted in Family 2
of copy number. CNV  copy number variant; Ex  exon; Int  intron; MLPA  Mubsent from 9 healthy members (Table 1). Linkage analysis mas performed to evaluate segregation between the deletion
nd the LQT phenotype. Under the dominant model of
nheritance, we obtained a maximum logarithm of the odds
LOD) score of 3.13 (  0%).
amily 2. The proband is a woman diagnosed at age 28 years
ith LQTS after the occurrence of syncope triggered by
coustic stimulus (phone ringing). Her ECG showed a pro-
onged QT interval (QTc  563 ms) and a bifid T-wave.
CGs were performed in the first-degree relatives: the mother,
he brother, and the 2 sons (Fig. 4A). Prolongation of the QT
nterval was found only in the mother (I:2; QTc  467 ms).
MLPA analysis showed a heterozygous deletion of
CNH2 (Fig. 2B). QMPSF confirmed the deletion of
CNH2 (probes in exons 5 and 15) and showed the deletion
f ABP1 (probe in exon 2; data not shown). Array CGH
nalysis revealed that the CNV is 145 kb in length (probe
_16_P18165049 to probe A_16_P1835307) and includes
ntire copies of the KCNH2 and ABP1 genes (7q36.1)
Fig. 3B).
The same CNV was also found in 2 relatives: her affected
in 3 Long QT Patients by MLPA
SCN5A. The asterisks mark the detection of exonic deletions. (A) KCNH2/exons
KCNQ1/exons 7 to 8 are deleted in Family 3. Y-axis represents the relative ratio
Ligation-dependent Probe Amplification.enes
, and
; (C)
ltiplexother (I:2) and her healthy brother (II:1) (Table 1).
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Copy Number Variation in LQTS Genes December 28, 2010/January 4, 2011:40–7amily 3. Patient II.1 was a girl diagnosed at age 14 years
ith the LQTS after the occurrence of an episode of
yncope resulting from a stress with a temporary loss of
earing and tachycardia. Her ECG showed a prolonged QT
nterval (QTc  490 ms) as well as a broad-base T-wave
orphology on derivations V4 to V6. Her father presented
ith a T-wave pattern suggestive of LQT1 and a borderline
Tc duration of 438 ms (Fig. 4B). Her mother and sister
ave normal T-wave morphology and QT interval duration
data not shown).
We identified by MLPA 1 heterozygote deletion that
Figure 3 Array-Based CGH Allows Better Delineation of Deletio
(A) The proband from Family 1 carries a 650-kb-long deletion including KCNH2 an
deletion including KCNH2 and APB1. Black arrows indicate the clones flanking theaps to band 11p15.5 and is restricted to KCNQ1 exons 7 Snd 8 in proband II:1 (Fig. 2C). The CNV was confirmed
y 2 independent techniques: QMPSF with probes in exons
and 8, and qPCR with primers in exons 7 and 8 as well as
ntron 7-8 (data not shown). The CNV was inherited from
he proband’s father (I:1), whereas the proband’s sister (II:2)
id not carry the deletion (Fig. 4B, Table 1).
iscussion
NV detection in LQTS genes. In this study, we evalu-
ted the involvement of CNVs in KCNQ1, KCNH2, and
akpoints
ther genes. (B) The proband in Family 3 carries a 145-kb-long
ion breakpoints. CGH  comparative genomic hybridization.n Bre
d 19 o
deletCN5A genes in patients affected by a typical form of
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December 28, 2010/January 4, 2011:40–7 Copy Number Variation in LQTS GenesQTS, for whom previous molecular analysis had failed to
dentify point mutations in the known major LQTS genes.
e detected 3 CNVs in 3 unrelated patients: 1 deletion in
CNQ1 and 2 deletions involving KCNH2.
unctional effect of the CNVs. The first deletion includes
he exons 4 to 15 of KCNH2. This deletion could lead to a
runcated protein. More probably, its effect may be similar
o that of a premature termination codon mutation with
ubsequent nonsense-mediated decay degradation of the
CNH2 mRNA (28). Although this deletion includes 19
ther genes, the patient presented with no abnormal phe-
otype other than prolonged QT duration.
The second deletion includes the whole KCNH2
ene, probably leading to haploinsufficiency and decreas-
ng levels of the potassium current IKr (rapid components
f the delayed rectifier potassium current) in ventricular
ardiomyocytes.
The third deletion spans exons 7 to 8 of KCNQ1.
ssuming that the deletion includes full copies of both
xons, it leads to the lack of the second part of the p-loop
including GYGD motif), as well as the S6 transmembrane
egment and 23 amino acids from the C-terminal part of the
vLQT1 channel subunit. Interestingly, previous studies
ave described splicing variants, involving deletion of either
linical and Genetic Data for Families 1, 2, and 3Table 1 Clinical and Genetic Data for Families 1, 2, and 3
Individual Sex Age (yrs) QTc (ms)
Family 1
I:1 M 72 422
I:2 F 70 465
II:1 M 50 590
II:2 F 50 430
II:3 M 45 392
II:4 M 41 388
II:6 M 46 430
II:7 F 49 505
III:1 M 16 670
III:2 F 22 421
III:3 F 29 442
III:4 (proband) F 25 554 Td
III:5 F 18 518
III:6 F 18 610
III:7 F 24 438
III:8 F 22 423
Family 2
I:2 F 53 467
II:1 M 30 402
II:3 (proband) F 31 563 S
III:1 M 7 389
III:2 M 3 437
Family 3
I:1 M 49 438
I:2 F 53 438
II:1 (proband) F 18 490 S
II:2 F 20 431
NV  copy number variation; SD  sudden death; TdP  torsades de pointes; VF  ventricular fixon 7, exon 8, or both, leading to decreased IKs (slow pomponents of the delayed rectifier potassium current)
29,30).
amily segregation analysis. We found perfect cosegrega-
ion between long QT phenotype and CNV inheritance in
amily 1 (odds [LOD] score 3), demonstrating that the
CNH2 deletion is responsible for this familial form of
QTS. One nonpenetrant patient (II:1) was identified in
amily 2, in line with the observations of a previous study
rom others (31). In Family 3, the KCNQ1 deletion was
ound in 2 members presenting a T-wave pattern suggestive
f LQT1. One of them presents with a prolonged QTc
uration, the other with a borderline value (Fig. 4B).
linical implications. The 3 deletions identified are ex-
ected to lead to haploinsufficiency. Nonsense mutations or
rameshift mutations brought about 50% reduction in
ardiac repolarizing IKs or IKr potassium channel current.
hey are associated with a less severe phenotype than
ominant-negative mutations but are known to cause sud-
en cardiac death (32). This less severe phenotype can
xplain the nonpenetrant case in Family 2 and the number
f asymptomatic individuals. Furthermore, it is known that
he nonpenetrant mutation carriers found in familial studies
ould experience syncope or cardiac arrest (33). However,
ore CNV studies are required to establish a genotype–
Symptoms Phenotype CNV Carrier/Noncarrier
— Unaffected Noncarrier
— Affected Carrier
— Affected Carrier
— Unaffected Noncarrier
— Unaffected Noncarrier
— Unaffected Noncarrier
— Unaffected Noncarrier
— Affected Carrier
— Affected Carrier
— Unaffected Noncarrier
— Unaffected Noncarrier
SD resuscitated Affected Carrier
— Affected Carrier
— Affected Carrier
— Unaffected Noncarrier
— Unaffected Noncarrier
— Affected Carrier
— Unaffected Carrier
(after phone ringing) Affected Carrier
— Unaffected Noncarrier
— Undetermined Noncarrier
— Undetermined Carrier
— Unaffected Noncarrier
(after stress) Affected Carrier
— Unaffected Noncarrier
on.P/VF/
yncope
yncopehenotype correlation.
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Copy Number Variation in LQTS Genes December 28, 2010/January 4, 2011:40–7Indeed, our approach is focused on the exonic portions of
he 3 most relevant genes involved in LQTS. We can expect
hat other functional and also nonfunctional CNVs may
xist within the portions of the genes that have not been
nvestigated (introns, regulatory elements, coding region not
overed by the MLPA kit).
We note that similarly to that observed for the previously
escribed point mutations, the T-wave morphologies ob-
erved in probands’ ECGs are predictive for which LQTS
ene is altered by CNV and thus remain a relevant indicator
f the morbid gene (34).
onclusions
n summary, our study demonstrates that CNVs involving
ajor LQTS genes explain around 3% of additional LQTS
ases (3 out of 93 patients, 95% confidence interval [CI]:
.007 to 0.09) after failure of the classical molecular diag-
ostic screen (dHPLC and direct sequencing). This fre-
uency corresponds to the percentage of CNVs versus point
Figure 4 Families 2 and 3: Clinical Findings
(A) Family 2 and (B) Family 3. The disease phenotype is transmitted as an autoso
phenotypes; gray symbols, undetermined members; and question marks, unknow
cated by arrows. Genotypes are marked with / for heterozygous mutation and
ECG are presented for affected members with ECG of arrhythmia when documenteutations already described in the published reports for a forbid gene such as BRCA1 (35). In our and others’
xperience, the frequency of CNV detection in KCNH2 and
CNQ1 is higher than the frequency of point mutations in
NKB, KCNE1, KCNE2, KCNJ2, CACNA1C, CAV3,
CN4B, AKAP9 and SNTA1 together (4,20). Thus, we
onclude that CNV detection in the 2 major LQTS genes
ay be performed for patients diagnosed with LQTS when
o point mutation has been detected by sequencing for
CNQ1, KCNH2, and SCN5A. In our experience (0 of 93
atients, 95% CI: 0 to 0.039) and from results of another
tudy, CNVs involving SCN5A seems to be extremely rare
n LQTS (36).
Our study demonstrates that genomic rearrangements in
CNQ1 and KCNH2 genes explain 3% of the LQTS cases
n which no point mutation was found in the genes
ommonly involved. In consequence, we propose that
creening for genomic rearrangement may be considered in
he routine workup of LQTS in the absence of point
utations in the 3 major LQTS genes and before screening
ominant trait. Open symbols depict unaffected members; solid symbols, long QT
otypes. Circles indicate females; and squares, males. The probands are indi-
or wild type. QTc values (Bazett formula) are indicated below each individual.
reviations as in Figure 1.mal-d
n phen
/ f
d. Abbor point mutations in other LQTS genes.
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